Carolyn Martin
Optometrist · Sedona, AZNPI 1255304754
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $838 of the $1,134 with a category attached, or 73.9%. Johnson & Johnson Vision Care, Inc. accounts for 80.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $873 and has fallen 93.4% since, to $58 in 2025.
Across 12 payments — averaging $94.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$909
- Sight Sciences, Inc.$128
- Tarsus Pharmaceuticals, Inc.$42
- LKC Technologies, Inc.$19
- Dompe US, Inc.$16
- Sun Pharmaceutical Industries Inc.$14
- plus $5 from 1 others
What the payments were for
- Consulting fees$83874%
- Food & beverage$29626%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 5 | $909 |
| Sight Sciences, Inc. | 2 | $128 |
| Tarsus Pharmaceuticals, Inc. | 1 | $42 |
| LKC Technologies, Inc. | 1 | $19 |
| Dompe US, Inc. | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Maculogix, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,134 in reported general payments places this provider in the 55th percentile of 1,134 optometrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 19 | $22,064 |
| Alphagan PBrimonidine Tartrate | 19 | $11,984 |
| VyzultaLatanoprostene Bunod | 28 | $11,094 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 32 | $4,920 |
| Latanoprost | 196 | $2,443 |
| Brinzolamide | 13 | $2,333 |
| Brimonidine Tartrate | 28 | $1,837 |
| TafluprostTafluprost/Pf | 12 | $1,322 |
| Prednisolone Acetate | 42 | $1,262 |
| Difluprednate | 11 | $1,043 |
| Timolol Maleate | 46 | $792 |
| Acyclovir | 20 | $576 |
| Dorzolamide Hcl | 29 | $437 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $363 |
| Ofloxacin | 22 | $307 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Sedona
- Marc BloomensteinScottsdale$1.4M
- Stephanie WooLake Havasu City$538K
- Jashpal RajasansiGilbert$104K
- Jamie KuhnGlendale$37K
- Tania SobchukLake Havasu City$32K
- Stephen CohenScottsdale$32K
- Andrew ZagelbaumScottsdale$25K
- Linda TrinhPeoria$22K
- Jason BaileyGilbert$17K
- Mike WuTucson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.